Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

City of Hope Researchers Find “Achilles' Heel” in B Cell Tumors

March 14, 2018 | Katie Neith

In a new paper published in the journal Cell, a team of researchers led by City of Hope’s Markus Müschen, M.D., Ph.D., and Gang Xiao, Ph.D., reports on the discovery of a new therapeutic target for these B cell malignancies.

‘Goldilocks’ Therapies Could Be a Breakthrough for Patients with Lymphoma

March 6, 2018 | City of Hope

Thanks to research being done by City of Hope's Markus Müschen, M.D., Ph.D., lymphoma patients may soon receive treatments that leverage quality control mechanisms that our own immune systems utilize to fight harmful antibodies.

5 Things to Know About Skin Cancer

February 5, 2018 | Kevin Chesley

Skin cancer is the most commonly diagnosed malignancy. Most forms are not life-threatening, except for the rarest form, melanoma. However, even this most aggressive form of skin cancer has a high cure rate, thanks to new leading-edge treatments.

Larry Kwak, M.D., Ph.D., Receives Grant for Promising Lymphoma Work

January 12, 2018 | Letisia Marquez

Larry Kwak, M.D., Ph.D., received a grant to support his work with mantle cell lymphoma from the Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to fighting blood cancer.

Meet Our Doctors: Farah Abdulla, M.D.

January 12, 2018 | Josh Jenisch

Dermatologist and dermatopathologist Farah Abdulla, M.D., said that one reason she was so excited to accept a position at City of Hope is the level of resources available to patients, even those who lack access to care.

Combination Immunotherapy Shown to Be Effective Initial Treatment for Relapsed or Refractory Hodgkin Lymphoma

December 11, 2017 | Katie Neith

Researchers led by Alex Herrera, M.D. have found that a combination of two immunotherapy drugs may be a more tolerable way for patients to fight the disease before a transplant.

2018 Rose Parade: First pitch symbolizes new beginning for Division 1 baseball player

November 28, 2017 | Denise Heady

For the 46th year in a row, City of Hope will participate in the Tournament of Roses Parade. This year, 10 patients will welcome 2018 atop City of Hope’s Rose Parade float. Here, we meet float rider Chad Bible, a 21-year-old college student and Division 1 baseball player at San Diego State University.

2018 Rose Parade: ‘I Just Want to Help’: A Platelet Donor Gives Back to Honor His Mom

October 20, 2017 | Denise Heady

Ever since Bliley's mother passed away from Hodgkin lymphoma when he was 8 years old, he knew he wanted to help other patients like his mom. He just wasn’t sure how. When he turned 18, he finally found a way – by donating platelets to cancer patients who desperately needed transfusions to live.

Load More
/* */